Loading the player.
Pfizer must conduct local study for vaccine approval: VK Paul
Any vaccine maker, including Pfizer, which has sought emergency-use authorisation for its Covid-19 shot in India, must conduct a local bridging safety and immunogenicity study to be considered for the country s immunisation programme, a senior government official told Reuters. Serum Institute of India, the local manufacturer of the vaccine developed by AstraZeneca and Oxford University, has done a similar study on more than 1,500 people over months before seeking and receiving emergency approval in the country.
Bird Flu: Chicken sales banned in parts of Delhi; restaurants, hotels warned of action
Budget 2021 podcast | How govt can help healthcare sector become self-reliant post-COVID
After the vaccination drive, India s healthcare sector hopes to become self-reliant. How can the government help? January 14, 2021 / 12:37 PM IST
Healthcare is expected to be a central topic in the Union Budget 2021, due to the coronavirus pandemic.
In this special podcast ahead of the Budget on February 1, Moneycontrol s Anubhav Sahu explains how the government will have to address both transitional and strategic needs of the sector. Transitional needs include the execution of the vaccination drive, while the strategic needs include focus on public health expenditure and making the Indian healthcare system self-reliant.
Budget 2021 podcast | Auto Industry hopes to hear more on Make in India and Electric Vehicles
Moneycontrol s Nitin Agrawal talks about what the automobile sector expects from the Budget. January 14, 2021 / 10:10 AM IST
In this special podcast ahead of the Union Budget 2021, Moneycontrol s Nitin Agrawal talks about how the automobile industry fared in the year 2020 and what the sector expects from the Budget.
In the last couple of Budgets the government has provided indirect support to auto companies through the Make in India initiative and focus on rural economy and infrastructure, and the sector expects this support to continue in 2021.
The sector hopes to see more incentives to widen the adoption of electric vehicles in the country, and some clarity on the scrappage policy.
Corporate Buzz podcast | Bharat Biotech vs Serum Institute war not over; Mahindra lags in the auto race; Will India s vaccine drive be efficient?
Moneycontrol s Keerthana Tiwari and Prince Thomas talk about the top news from India Inc. January 08, 2021 / 07:08 PM IST
In this episode of the Corporate buzz podcast, host Keerthana Tiwari and Moneycontrol s Corporate Bureau Chief Prince Thomas talk about the top news from India Inc.
Thomas talks about how prepared India is to distribute the vaccines. He also explains why the tussle between Bharat Biotech and Serum Institute may not be over.
He then describes the new rule in the H-1B selection process that will come into effect on March 9.
Loading the player.
Coronavirus impact: Govt extends deadline for income tax filing, GST compliance
The government has extended various tax compliance deadlines, including Income Tax Returns, tax audit reports and declaration under Vivad Se Vishwas Scheme, in view of the challenges faced by taxpayers in meeting the statutory and regulatory compliances due to the outbreak of COVID-19 pandemic.
Farmers protest: Consensus between unions, govt on 2 issues, next talks on Jan 4 The sixth round of talks between the Centre and farmers union leaders over farm laws concluded on Wednesday. The next round of talks is scheduled to be held on January 4 since consensus was achieved on only two issues.